Skip to content

Author

J. Fraietta

We have 2 of 25 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Decade-long persistence of CD19 CAR T cells in B cell lymphomas

Chimeric antigen receptor (CAR) T cell therapy induces durable remissions in lymphoid malignancies, yet the extent and biology of long-term CAR T cell persistence in B cell lymphoma remain unclear. Here we report the persistence and characteristics of 4-1BB-costimulated anti-CD19 CAR T cells (CART19) up to 10 years aft...

L. Paruzzo, E. Chong, Elise A. Chong et al. · 0 citations
Review Open access Sep 2026

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Most molecularly characterized post-CAR T-cell lymphomas lack evidence of CAR vector-driven transformation and appear to reflect pre-existing or therapyselected clonal T-cell populations in the context of clonal hematopoiesis, immune dysregulation, and, in some cases, viral reactivation.

Federico Stella, J. Fraietta, S. Schuster et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.